Degradation of Amyloid-β Species by Multi-Copper Oxidases
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Multi-copper oxidases (MCOs) can degrade amyloid-beta (Aβ) peptides, offering a new therapeutic strategy for Alzheimer's disease (AD). Ascorbate oxidase (AO) showed significant potential in rescuing neuron toxicity and preventing synaptic deficits.
Area Of Science
- Biochemistry
- Neuroscience
- Enzymology
Background
- Alzheimer's disease (AD) therapeutics often focus on reducing amyloid-beta (Aβ) production.
- Aβ degradation remains an underexplored therapeutic avenue for AD.
- Multi-copper oxidases (MCOs) are enzymes with potential but uninvestigated roles in Aβ clearance.
Purpose Of The Study
- To investigate the Aβ-degrading potential of MCOs.
- To evaluate MCOs as a novel therapeutic strategy for Alzheimer's disease.
Main Methods
- Assessed MCOs' Aβ degradation using electrophoresis.
- Validated ceruloplasmin (CP)-Aβ interactions via advanced microscopy and spectroscopy.
- Evaluated ascorbate oxidase (AO) in induced pluripotent stem (iPS) neuron cells and ex vivo brain slices.
Main Results
- CP and other MCOs demonstrated Aβ degradation capabilities.
- AO exhibited the most potent Aβ degradation among tested MCOs.
- AO treatment rescued Aβ oligomer-induced neurotoxicity and prevented hippocampal synaptic transmission deficits.
Conclusions
- This study is the first to report MCOs' peptide/protein degrading function.
- MCOs, particularly AO, show promise for Alzheimer's disease treatment.
- Further research into MCOs for AD therapy is warranted.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Activated manganese(IV) oxide can selectively oxidize allylic and benzylic alcohols via a radical intermediate mechanism. Primary allylic alcohols are oxidized to aldehydes, while secondary allylic alcohols yield ketones. The redox reaction of potassium permanganate with an Mn(II) salt such as manganese sulfate (under either alkaline or acidic conditions), followed by thorough drying, yields the oxidizing agent: activated MnO2. While MnO2 is insoluble in the solvents used for the reaction, the...